- PRODUCTS
-
UP.SIGHT™ 2nd GenNEW
Optimized For Proof Of Monoclonality, Colony Tracking, Confluency, & Titer Measurement -
F.SIGHT™ 2.0
Optimized For Rapid Dispensing of Fluorescent Cells -
C.SIGHT™ 2.0
Optimized for Powerful Dispensing of Unlabeled Cells -
B.SIGHT™
Optimized For Rapid Microbial Single-Cell Isolation and Cultivation -
F.SIGHT™ OMICS
Optimized For Single-Cell-Omics -
F.SIGHT™
Optimized For Affordability And Flexibility -
C.SIGHT™
Optimized for Affordable Cell Line Development -
Compare Products
Decide which one is right for you - Help Me Choose
-
UP.SIGHT™ 2nd GenNEW
- APPLICATIONS
- RESOURCES HUB
- COMPANY
- SHOP
The #BIOCONVERGENCE revolution is here, and we’re proud to be leading the charge. Today, we embarked on our transition to BICO (formerly CELLINK), a new business structure concentrating on the intersection of biology and technology. Since our founding in 2016, we’ve built one of the world’s most expansive portfolio of life science products, and this change will enable BICO and its 11 subsidiaries to innovate like never before.
CYTENA is proud to be a part of the Bioconvergence revolution and are committed
Learn more about our movement, visit bico.com